Venus Concept (VERO) Granted 510(k) Clearance for Venus BlissMAX
Get Alerts VERO Hot Sheet
Join SI Premium – FREE
Venus Concept Inc. (NASDAQ: VERO) today announced that it has received a 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) to market the Venus BlissMAX device (“BlissMAX”) with an expanded indication for use in new areas of the body and an increase in RF energy output.
“We are excited to receive this new 510(k) clearance for BlissMAX, the next generation of our Venus Bliss system, which expands its indication for use to include non-invasive lipolysis of the back and thighs – in addition to the abdomen and flanks – in individuals with a Body Mass Index of 30 or less,” said Domenic Serafino, Chief Executive Officer of Venus Concept. “We believe BlissMAX is the only technology on the market to offer laser fat reduction, cellulite reduction and muscle conditioning in a single body contouring workstation, and this new 510(k) clearance further expands its versatility. In addition, increasing maximum RF energy output by 50% allows for more efficiency and flexibility in treatments, which ultimately increase revenue for our customers. With the recent commercial launch of BlissMAX during the second quarter of this year, we are pleased to make this compelling addition to our body treatment franchise available to our physician customers, providing them with a cost-effective platform to deliver compelling results with little-to-no downtime.”
BlissMAX is a medical aesthetic platform that offers a comprehensive solution for fat reduction, cellulite reduction and muscle conditioning with three technologies in one platform. Like the Company’s Venus Bliss™ system, BlissMAX employs advanced diode laser applicators for non-invasive lipolysis of the abdomen, flanks, back and thighs in individuals with a Body Mass Index of 30 or less, resulting in reduction of unwanted focal fat, as well as an (MP)2 applicator that combines Multi-Polar Radio Frequency and Pulsed Electro Magnetic Fields with advanced VariPulse™ technology to reduce the appearance of cellulite. In addition to these technologies, BlissMAX also features the Company’s FlexMAX EMS applicators, designed for muscle conditioning to stimulate healthy muscles.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Venus Concept (VERO) Announces Loan Purchase and Completion of First Phase of Refinancing
- Day One Biopharmaceuticals' (DAWN) OJEMDA Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor
- Amneal Pharmaceuticals (AMRX) Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
Create E-mail Alert Related Categories
Corporate News, FDARelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!